Folate Analog Metabolic Inhibitor [EPC]

Folate Analog Metabolic Inhibitor [EPC] was reported 440072 times

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 292 0.8690
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5927 0.8264
2 RHEUMATOID FACTOR POSITIVE 4559 0.7885
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 518 0.7754
4 SWOLLEN JOINT COUNT INCREASED 2456 0.7694
5 PEMPHIGUS 9036 0.7220
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1658 0.7190
7 RHEUMATIC FEVER 3208 0.7190
8 SYNOVITIS 12408 0.6875
9 LUPUS VULGARIS 865 0.6865
10 C-REACTIVE PROTEIN ABNORMAL 4362 0.6793
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 1352 0.6750
12 DUODENAL ULCER PERFORATION 4955 0.6656
13 HAND DEFORMITY 8524 0.6492
14 C-REACTIVE PROTEIN 599 0.6462
15 GRANULOMA SKIN 497 0.6054
16 FACET JOINT SYNDROME 1943 0.5962
17 RHEUMATOID NODULE 1554 0.5637
18 X-RAY ABNORMAL 965 0.5391
19 BONE EROSION 1871 0.5285
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1089 0.5251
21 DISLOCATION OF VERTEBRA 1175 0.5147
22 BODY HEIGHT BELOW NORMAL 327 0.5086
23 MUSCLE INJURY 4205 0.5070
24 HELICOBACTER INFECTION 5136 0.4992
25 SERONEGATIVE ARTHRITIS 550 0.4799
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3094 0.4759
27 FOLLICULITIS 4929 0.4696
28 RETINITIS 781 0.4517
29 CONTRAINDICATED PRODUCT ADMINISTERED 13306 0.4390
30 ENTHESOPATHY 684 0.4371
31 RHEUMATOID LUNG 405 0.4241
32 DACTYLITIS 407 0.4145
33 PERICARDITIS 6687 0.3976
34 PERIPHERAL VENOUS DISEASE 1605 0.3926
35 BLOOD PRESSURE DIASTOLIC ABNORMAL 981 0.3853
36 BLOOD PARATHYROID HORMONE DECREASED 562 0.3790
37 JOINT DESTRUCTION 589 0.3785
38 GLOSSODYNIA 8477 0.3783
39 BLOOD PRESSURE SYSTOLIC ABNORMAL 935 0.3779
40 DRUG TOLERANCE DECREASED 1037 0.3689
41 LYMPHOPROLIFERATIVE DISORDER 1079 0.3670
42 JUVENILE IDIOPATHIC ARTHRITIS 863 0.3525
43 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3869 0.3493
44 TENOSYNOVITIS 964 0.3491
45 DRUG CLEARANCE DECREASED 450 0.3443
46 RHEUMATOID ARTHRITIS 38662 0.3402
47 ACUTE GRAFT VERSUS HOST DISEASE 1518 0.3313
48 CHRONIC GRAFT VERSUS HOST DISEASE 1173 0.3246
49 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 561 0.3171
50 HYPOFIBRINOGENAEMIA 313 0.3155
51 BLOOD IRON ABNORMAL 307 0.3142
52 GRIP STRENGTH DECREASED 2764 0.3137
53 PANNICULITIS 748 0.3088
54 SYSTEMIC LUPUS ERYTHEMATOSUS 10889 0.3065
55 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 843 0.3047
56 ARTHRODESIS 306 0.3006
57 JOINT RANGE OF MOTION DECREASED 4012 0.2988
58 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 408 0.2887
59 FINGER DEFORMITY 1389 0.2865
60 WOUND 8009 0.2862
61 HISTOPLASMOSIS DISSEMINATED 415 0.2613
62 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 337 0.2559
63 CENTRAL NERVOUS SYSTEM LYMPHOMA 346 0.2509
64 FEBRILE BONE MARROW APLASIA 1067 0.2508
65 PSORIATIC ARTHROPATHY 10177 0.2505
66 ARTHROPATHY 13502 0.2427
67 BREAST CANCER STAGE III 1551 0.2392
68 BURSITIS 2878 0.2370
69 IRRITABLE BOWEL SYNDROME 5023 0.2340
70 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 495 0.2324
71 POLYARTHRITIS 1211 0.2295
72 FOOT DEFORMITY 2536 0.2286
73 ONYCHOMADESIS 955 0.2273
74 THERAPEUTIC PRODUCT EFFECT DECREASED 10170 0.2268
75 LEUKOENCEPHALOPATHY 818 0.2194
76 FIBROMYALGIA 5321 0.2187
77 WOUND INFECTION 2380 0.2171
78 DRUG SPECIFIC ANTIBODY 296 0.2161
79 LIP DRY 1943 0.2137
80 ONYCHOMYCOSIS 934 0.2127
81 MYELOPATHY 404 0.2125
82 GRAFT VERSUS HOST DISEASE IN SKIN 463 0.2100
83 HYPERCHOLESTEROLAEMIA 2029 0.2099
84 DRUG INTOLERANCE 20148 0.2084
85 C-REACTIVE PROTEIN INCREASED 7295 0.2003
86 JOINT ARTHROPLASTY 357 0.1992
87 SACROILIITIS 375 0.1985
88 PSEUDOMONAL SEPSIS 348 0.1985
89 IMPAIRED HEALING 6443 0.1960
90 JOINT EFFUSION 1326 0.1921
91 CYTOMEGALOVIRUS CHORIORETINITIS 371 0.1901
92 JOINT SWELLING 22691 0.1878
93 SCLERITIS 298 0.1859
94 PULMONARY FIBROSIS 3559 0.1853
95 SYNOVIAL CYST 852 0.1843
96 VENOOCCLUSIVE LIVER DISEASE 910 0.1841
97 ANTIBODY TEST POSITIVE 304 0.1830
98 TUBERCULIN TEST POSITIVE 458 0.1807
99 TREATMENT FAILURE 14989 0.1807
100 OSTEOARTHRITIS 7670 0.1807
101 GRAFT VERSUS HOST DISEASE 1298 0.1803
102 PUSTULAR PSORIASIS 617 0.1795
103 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 453 0.1754
104 MUCOSAL INFLAMMATION 4560 0.1740
105 HUMAN HERPESVIRUS 6 INFECTION 325 0.1718
106 LOWER RESPIRATORY TRACT INFECTION 7751 0.1703
107 ARTHRITIS BACTERIAL 699 0.1702
108 EXOSTOSIS 1534 0.1678
109 INFUSION RELATED REACTION 10931 0.1648
110 AUTOIMMUNE DISORDER 1596 0.1636
111 LIVE BIRTH 1359 0.1623
112 ALANINE AMINOTRANSFERASE ABNORMAL 342 0.1620
113 DISSEMINATED TUBERCULOSIS 415 0.1616
114 HEPATIC ENZYME INCREASED 11000 0.1612
115 EPSTEIN-BARR VIRUS INFECTION 998 0.1596
116 LIVER INJURY 3918 0.1595
117 NAIL DISORDER 1361 0.1554
118 SCIATICA 2475 0.1551
119 BLOOD PRESSURE DIASTOLIC DECREASED 1141 0.1544
120 PNEUMOCYSTIS JIROVECI PNEUMONIA 344 0.1543
121 VENOOCCLUSIVE DISEASE 383 0.1528
122 CYSTITIS HAEMORRHAGIC 616 0.1527
123 LATENT TUBERCULOSIS 318 0.1517
124 HIP ARTHROPLASTY 2324 0.1516
125 KNEE ARTHROPLASTY 3181 0.1509
126 BLEPHAROSPASM 949 0.1506
127 MUSCULOSKELETAL STIFFNESS 13200 0.1505
128 ADENOVIRUS INFECTION 436 0.1502
129 CYTOMEGALOVIRUS INFECTION REACTIVATION 660 0.1493
130 LUPUS-LIKE SYNDROME 1349 0.1486
131 JOINT STIFFNESS 3806 0.1449
132 HISTIOCYTOSIS HAEMATOPHAGIC 427 0.1437
133 LUNG ADENOCARCINOMA 431 0.1431
134 STOMATITIS 8687 0.1431
135 OBESITY 2279 0.1429
136 PULMONARY TUBERCULOSIS 611 0.1429
137 PNEUMOCYSTIS JIROVECII PNEUMONIA 1428 0.1421
138 ASPERGILLUS INFECTION 930 0.1416
139 FAECAL CALPROTECTIN INCREASED 445 0.1404
140 DIFFUSE LARGE B-CELL LYMPHOMA 1082 0.1403
141 INFLAMMATION 7201 0.1394
142 BLOOD PRESSURE DIASTOLIC INCREASED 638 0.1381
143 SPINAL STENOSIS 567 0.1372
144 HEPATIC FIBROSIS 471 0.1371
145 CUSHINGOID 440 0.1369
146 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 301 0.1364
147 SKIN NECROSIS 707 0.1361
148 CYTOMEGALOVIRUS VIRAEMIA 603 0.1354
149 SHOULDER ARTHROPLASTY 365 0.1354
150 LIVER FUNCTION TEST INCREASED 2905 0.1352
151 SWELLING 12651 0.1350
152 NODULE 1752 0.1341
153 INFLAMMATORY MARKER INCREASED 663 0.1336
154 B-CELL LYMPHOMA 453 0.1332
155 CHONDROPATHY 359 0.1324
156 JOINT DISLOCATION 1390 0.1314
157 DEMYELINATION 532 0.1297
158 ANKYLOSING SPONDYLITIS 1708 0.1295
159 TYPE 2 DIABETES MELLITUS 4359 0.1293
160 PANCYTOPENIA 7087 0.1267
161 SARCOIDOSIS 602 0.1266
162 MOUTH ULCERATION 2659 0.1261
163 BK VIRUS INFECTION 425 0.1259
164 BASAL CELL CARCINOMA 1963 0.1257
165 UVEITIS 1704 0.1255
166 FINE MOTOR SKILL DYSFUNCTION 358 0.1236
167 ARTHRITIS INFECTIVE 573 0.1234
168 INFUSION SITE REACTION 367 0.1227
169 HAEMATOTOXICITY 1164 0.1224
170 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1169 0.1223
171 DERMATOMYOSITIS 309 0.1218
172 BLOOD PRESSURE SYSTOLIC INCREASED 2365 0.1211
173 SPONDYLITIS 439 0.1206
174 WALKING AID USER 783 0.1186
175 PULMONARY TOXICITY 832 0.1175
176 PNEUMONIA VIRAL 374 0.1172
177 FEBRILE NEUTROPENIA 7772 0.1170
178 SENSITIVITY TO WEATHER CHANGE 613 0.1164
179 DISCOMFORT 7102 0.1163
180 ANTINUCLEAR ANTIBODY POSITIVE 375 0.1153
181 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 864 0.1150
182 ARTHRITIS 9032 0.1147
183 MOBILITY DECREASED 8245 0.1146
184 MUSCULOSKELETAL PAIN 5942 0.1133
185 BLOOD CULTURE POSITIVE 339 0.1131
186 MUCORMYCOSIS 294 0.1130
187 MATERNAL EXPOSURE TIMING UNSPECIFIED 422 0.1122
188 INJECTION SITE HAEMATOMA 1615 0.1112
189 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5345 0.1112
190 BLISTER 6189 0.1101
191 BODY TEMPERATURE DECREASED 1082 0.1098
192 BRONCHIECTASIS 738 0.1094
193 STAPHYLOCOCCAL SEPSIS 537 0.1087
194 BACK INJURY 1166 0.1071
195 FOOT OPERATION 530 0.1070
196 BLOOD CHOLESTEROL INCREASED 4972 0.1066
197 BLOOD PRESSURE FLUCTUATION 2550 0.1061
198 HEPATOTOXICITY 2363 0.1060
199 SINUSITIS 10862 0.1059
200 IMMUNOSUPPRESSION 931 0.1054
201 GAIT INABILITY 3522 0.1053
202 GRANULOMA 361 0.1042
203 JOINT LOCK 293 0.1031
204 IMMUNODEFICIENCY 1531 0.1026
205 BRONCHOPULMONARY ASPERGILLOSIS 793 0.1022
206 NON-SMALL CELL LUNG CANCER 489 0.1020
207 HEPATIC CIRRHOSIS 1899 0.1010
208 INJECTION SITE IRRITATION 1284 0.1008
209 LOWER LIMB FRACTURE 1932 0.1005
210 PULMONARY MASS 1488 0.0998
211 GASTROINTESTINAL TOXICITY 479 0.0996
212 APPARENT DEATH 356 0.0988
213 CREPITATIONS 293 0.0983
214 INFECTION 14141 0.0976
215 SKIN ULCER 2525 0.0976
216 NIGHT SWEATS 3147 0.0976
217 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6924 0.0972
218 ANAL FISSURE 516 0.0961
219 APHTHOUS ULCER 743 0.0957
220 IRITIS 291 0.0956
221 TENDERNESS 997 0.0956
222 HERPES SIMPLEX 614 0.0944
223 BACTERIAL SEPSIS 305 0.0936
224 SKIN PLAQUE 790 0.0936
225 BONE MARROW FAILURE 1883 0.0926
226 PRODUCT LABEL CONFUSION 538 0.0922
227 PHARYNGITIS 1143 0.0921
228 HEPATIC ENZYME ABNORMAL 459 0.0919
229 CYTOPENIA 1122 0.0915
230 PLEURISY 544 0.0915
231 DRUG TOLERANCE 463 0.0914
232 EAR PAIN 1775 0.0912
233 NEUTROPENIC SEPSIS 646 0.0904
234 CYTOMEGALOVIRUS INFECTION 1499 0.0901
235 INTENTIONAL PRODUCT USE ISSUE 7837 0.0894
236 ARTHRALGIA 37004 0.0889
237 PERIPHERAL SWELLING 13637 0.0884
238 THERAPY PARTIAL RESPONDER 1379 0.0883
239 HEPATIC STEATOSIS 1644 0.0882
240 THERAPY NON-RESPONDER 3950 0.0878
241 PYODERMA GANGRENOSUM 316 0.0878
242 HYPERTRANSAMINASAEMIA 610 0.0876
243 PRESCRIBED OVERDOSE 1696 0.0876
244 GASTROINTESTINAL DISORDER 7819 0.0872
245 LUNG DISORDER 4269 0.0870
246 COELIAC DISEASE 848 0.0864
247 TONSILLITIS 450 0.0861
248 PNEUMONIA FUNGAL 340 0.0861
249 ABDOMINAL DISCOMFORT 14455 0.0861
250 STAPHYLOCOCCAL BACTERAEMIA 373 0.0857
251 ULCER HAEMORRHAGE 573 0.0846
252 LIVER DISORDER 3745 0.0844
253 WHEELCHAIR USER 375 0.0843
254 HYPERTRIGLYCERIDAEMIA 492 0.0840
255 THROMBOTIC MICROANGIOPATHY 819 0.0840
256 ILL-DEFINED DISORDER 5103 0.0839
257 VIRAL UPPER RESPIRATORY TRACT INFECTION 399 0.0839
258 ERYTHEMA NODOSUM 293 0.0834
259 SPINAL OSTEOARTHRITIS 733 0.0834
260 DRUG SPECIFIC ANTIBODY PRESENT 539 0.0828
261 DIVERTICULITIS 2291 0.0826
262 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 420 0.0824
263 NEUROTOXICITY 1445 0.0824
264 SPINAL FUSION SURGERY 333 0.0820
265 CHRONIC SINUSITIS 306 0.0814
266 HEPATITIS 2086 0.0814
267 PSORIASIS 10638 0.0814
268 OSTEOPOROSIS 3350 0.0814
269 ADRENAL INSUFFICIENCY 988 0.0813
270 ABSCESS LIMB 346 0.0811
271 OESOPHAGEAL CANDIDIASIS 323 0.0810
272 ULCER 1287 0.0808
273 RHINOVIRUS INFECTION 313 0.0803
274 LYMPHOMA 1242 0.0803
275 IMMOBILE 350 0.0801
276 DEFORMITY 748 0.0799
277 POSTOPERATIVE WOUND INFECTION 539 0.0797
278 EAR INFECTION 2114 0.0794
279 RASH VESICULAR 384 0.0793
280 ANAL ABSCESS 428 0.0793
281 HERPES ZOSTER 4558 0.0792
282 SINUS CONGESTION 1068 0.0790
283 INTERVERTEBRAL DISC DEGENERATION 731 0.0789
284 TOOTH ABSCESS 803 0.0788
285 NASOPHARYNGITIS 14521 0.0787
286 ADVERSE REACTION 1040 0.0784
287 SKIN PAPILLOMA 314 0.0782
288 ENCEPHALITIS 540 0.0780
289 SEPTIC SHOCK 3385 0.0777
290 LUNG NEOPLASM 332 0.0777
291 ANAL FISTULA 414 0.0775
292 TOOTH INFECTION 1021 0.0774
293 INTERSTITIAL LUNG DISEASE 3741 0.0772
294 HYPOALBUMINAEMIA 598 0.0768
295 ALOPECIA 15028 0.0764
296 ORAL HERPES 1491 0.0763
297 MATERNAL EXPOSURE DURING PREGNANCY 6795 0.0762
298 LOCALISED INFECTION 1829 0.0756
299 MENISCUS INJURY 464 0.0754
300 ERYSIPELAS 379 0.0753
301 SQUAMOUS CELL CARCINOMA 710 0.0753
302 HYPERCALCAEMIA 927 0.0750
303 POOR VENOUS ACCESS 776 0.0749
304 RED CELL DISTRIBUTION WIDTH INCREASED 309 0.0743
305 NEPHROPATHY TOXIC 834 0.0742
306 ORGANISING PNEUMONIA 368 0.0742
307 SPINAL PAIN 870 0.0742
308 DRUG ERUPTION 1314 0.0741
309 VASCULITIS 863 0.0740
310 HYPOGAMMAGLOBULINAEMIA 486 0.0739
311 JOINT INJURY 1580 0.0739
312 MUSCULOSKELETAL DISORDER 1406 0.0738
313 RESPIRATORY TRACT CONGESTION 1171 0.0736
314 CARPAL TUNNEL SYNDROME 1031 0.0735
315 TIBIA FRACTURE 344 0.0733
316 ENTEROCOCCAL INFECTION 354 0.0732
317 MUSCLE SPASTICITY 900 0.0732
318 PNEUMONITIS 1992 0.0731
319 SUBCUTANEOUS ABSCESS 350 0.0729
320 FEAR OF INJECTION 520 0.0728
321 DRUG LEVEL BELOW THERAPEUTIC 401 0.0726
322 POST PROCEDURAL INFECTION 588 0.0722
323 RHINITIS 583 0.0722
324 HYPERBILIRUBINAEMIA 747 0.0720
325 ESCHERICHIA URINARY TRACT INFECTION 306 0.0719
326 GENERAL PHYSICAL HEALTH DETERIORATION 8291 0.0716
327 KLEBSIELLA INFECTION 361 0.0713
328 BACTERIAL INFECTION 1331 0.0713
329 MYELODYSPLASTIC SYNDROME 1028 0.0710
330 BODY TEMPERATURE INCREASED 1446 0.0708
331 NECK PAIN 3960 0.0708
332 SKIN LESION 1941 0.0707
333 PRESCRIBED UNDERDOSE 1408 0.0705
334 DRUG EFFECT INCOMPLETE 2559 0.0704
335 CYST 874 0.0703
336 UPPER RESPIRATORY TRACT INFECTION 3253 0.0703
337 ENTERITIS 449 0.0701
338 DISABILITY 1384 0.0699
339 CLOSTRIDIUM DIFFICILE COLITIS 741 0.0698
340 INJECTION SITE WARMTH 1435 0.0697
341 SKIN INFECTION 776 0.0691
342 HERPES VIRUS INFECTION 397 0.0689
343 LEUKOPENIA 3440 0.0687
344 ROTATOR CUFF SYNDROME 875 0.0681
345 ABSCESS 1082 0.0677
346 DRUG-INDUCED LIVER INJURY 2126 0.0677
347 CONDITION AGGRAVATED 20563 0.0676
348 BREAST CANCER STAGE II 562 0.0675
349 BRONCHITIS 4995 0.0674
350 PSEUDOMONAS INFECTION 576 0.0671
351 INJECTION SITE PAPULE 307 0.0670
352 APLASTIC ANAEMIA 350 0.0669
353 HYPERSENSITIVITY 12429 0.0669
354 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 549 0.0665
355 MYOSITIS 597 0.0665
356 BACTERAEMIA 789 0.0664
357 SLEEP DISORDER 4615 0.0653
358 HEART RATE DECREASED 2285 0.0650
359 MALIGNANT MELANOMA 862 0.0643
360 STREPTOCOCCAL INFECTION 357 0.0641
361 CONTUSION 6109 0.0634
362 ORAL DISORDER 465 0.0634
363 OSTEOMYELITIS 1141 0.0629
364 WHEEZING 3727 0.0628
365 SKIN TOXICITY 355 0.0628
366 TRANSAMINASES INCREASED 1396 0.0627
367 VAGINAL INFECTION 295 0.0626
368 PHARYNGOLARYNGEAL PAIN 333 0.0626
369 INTERVERTEBRAL DISC PROTRUSION 1369 0.0626
370 ACUTE MYELOID LEUKAEMIA 976 0.0626
371 RESPIRATORY DISORDER 1871 0.0625
372 OEDEMA 3381 0.0623
373 LUNG INFILTRATION 548 0.0620
374 CELLULITIS 3122 0.0619
375 ACUTE RESPIRATORY DISTRESS SYNDROME 1094 0.0618
376 PAIN IN EXTREMITY 18217 0.0618
377 STAPHYLOCOCCAL INFECTION 2039 0.0618
378 RESPIRATORY TRACT INFECTION 1609 0.0617
379 INJECTION SITE REACTION 4243 0.0616
380 TENDON DISORDER 402 0.0616
381 CANDIDA INFECTION 1040 0.0615
382 THERAPEUTIC RESPONSE DECREASED 3715 0.0612
383 LOCAL SWELLING 1065 0.0610
384 STRESS FRACTURE 328 0.0607
385 LIVER FUNCTION TEST ABNORMAL 1767 0.0607
386 SPINAL DISORDER 573 0.0604
387 HEPATIC CYTOLYSIS 770 0.0603
388 GASTROINTESTINAL INFECTION 541 0.0603
389 HYPERKERATOSIS 332 0.0601
390 SEPSIS 6702 0.0600
391 ORAL CANDIDIASIS 786 0.0596
392 GASTROINTESTINAL INFLAMMATION 465 0.0593
393 CYSTITIS 1888 0.0592
394 PYELONEPHRITIS 513 0.0591
395 PAIN 36222 0.0589
396 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1009 0.0588
397 PNEUMONIA BACTERIAL 540 0.0588
398 ESCHERICHIA INFECTION 483 0.0587
399 TENDONITIS 909 0.0586
400 OSTEOPENIA 889 0.0585
401 IMMUNE SYSTEM DISORDER 770 0.0584
402 DRUG INEFFECTIVE 77001 0.0584
403 ARTHROPOD BITE 432 0.0582
404 ROAD TRAFFIC ACCIDENT 2434 0.0581
405 ATELECTASIS 560 0.0579
406 FOOT FRACTURE 1095 0.0577
407 DYSLIPIDAEMIA 293 0.0576
408 MENINGITIS 385 0.0576
409 PHARYNGITIS STREPTOCOCCAL 620 0.0572
410 SKIN LACERATION 621 0.0571
411 CONGENITAL ANOMALY 441 0.0569
412 ALANINE AMINOTRANSFERASE INCREASED 3458 0.0563
413 INJECTION SITE PRURITUS 3766 0.0562
414 FISTULA 631 0.0561
415 DRUG EFFECT DECREASED 2964 0.0550
416 GASTROENTERITIS 801 0.0548
417 NERVE COMPRESSION 506 0.0548
418 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1549 0.0546
419 TENDON RUPTURE 674 0.0545
420 MUSCULOSKELETAL DISCOMFORT 939 0.0545
421 LUNG INFECTION 847 0.0545
422 IMPAIRED WORK ABILITY 1164 0.0544
423 MYELOSUPPRESSION 1960 0.0544
424 SQUAMOUS CELL CARCINOMA OF SKIN 328 0.0543
425 VIRAL INFECTION 1803 0.0541
426 DIVERTICULUM 385 0.0541
427 SENSORY LOSS 436 0.0541
428 CATARACT 3216 0.0539
429 PNEUMONIA 17469 0.0539
430 DERMATITIS ALLERGIC 678 0.0538
431 PULMONARY HAEMORRHAGE 421 0.0538
432 TONGUE DISORDER 389 0.0537
433 FUNGAL INFECTION 1791 0.0537
434 FREQUENT BOWEL MOVEMENTS 1448 0.0535
435 HEMIPARESIS 907 0.0535
436 HYPERTENSION 11332 0.0534
437 INJURY 3759 0.0534
438 COLITIS 2020 0.0532
439 ODYNOPHAGIA 318 0.0532
440 TOOTH FRACTURE 586 0.0531
441 KIDNEY INFECTION 1043 0.0531
442 THROMBOCYTOPENIA 5943 0.0531
443 TUMOUR LYSIS SYNDROME 466 0.0529
444 PYREXIA 18214 0.0526
445 LYMPHADENOPATHY 1851 0.0522
446 MASS 729 0.0521
447 FURUNCLE 412 0.0519
448 HEPATOMEGALY 510 0.0518
449 SKIN MASS 346 0.0518
450 BONE DISORDER 931 0.0510
451 RASH PUSTULAR 372 0.0510
452 COVID-19 PNEUMONIA 603 0.0510
453 SPUTUM DISCOLOURED 483 0.0509
454 WEIGHT INCREASED 11396 0.0508
455 VITAMIN D DECREASED 435 0.0508
456 LYMPHOPENIA 719 0.0508
457 PRODUCT USE ISSUE 9551 0.0508
458 ARTERIAL OCCLUSIVE DISEASE 399 0.0507
459 OROPHARYNGEAL PAIN 4690 0.0506
460 SPINAL COMPRESSION FRACTURE 418 0.0505
461 RENAL CYST 401 0.0504
462 DISSEMINATED INTRAVASCULAR COAGULATION 709 0.0503
463 NEUTROPENIA 6810 0.0500
464 UROSEPSIS 462 0.0500
465 EMPHYSEMA 503 0.0498
466 INJECTION SITE ERYTHEMA 6135 0.0494
467 BREAST MASS 331 0.0492
468 HEPATOCELLULAR INJURY 694 0.0489
469 DRUG LEVEL DECREASED 492 0.0483
470 RASH 21051 0.0482
471 PAPULE 340 0.0482
472 DIARRHOEA HAEMORRHAGIC 451 0.0482
473 LIGAMENT SPRAIN 477 0.0482
474 GINGIVAL PAIN 383 0.0481
475 RESPIRATORY RATE INCREASED 427 0.0480
476 SECRETION DISCHARGE 601 0.0479
477 CARDIOTOXICITY 427 0.0478
478 INFLUENZA 5329 0.0477
479 HEMIPLEGIA 397 0.0477
480 HYPOAESTHESIA 7131 0.0476
481 PELVIC FRACTURE 371 0.0476
482 DRUG RESISTANCE 1220 0.0474
483 DEVICE RELATED INFECTION 731 0.0474
484 ASPARTATE AMINOTRANSFERASE INCREASED 2510 0.0472
485 POLYNEUROPATHY 564 0.0471
486 EYE INFECTION 531 0.0470
487 MOTOR DYSFUNCTION 479 0.0470
488 DECREASED IMMUNE RESPONSIVENESS 461 0.0469
489 TASTE DISORDER 953 0.0469
490 ENCEPHALOPATHY 1151 0.0468
491 DELIRIUM 1622 0.0467
492 MULTI-ORGAN FAILURE 804 0.0465
493 RHINORRHOEA 3004 0.0464
494 INJECTION SITE INDURATION 602 0.0464
495 INCREASED TENDENCY TO BRUISE 426 0.0463
496 PRODUCTIVE COUGH 2209 0.0462
497 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2533 0.0461
498 EPILEPSY 1411 0.0461
499 MATERNAL EXPOSURE BEFORE PREGNANCY 315 0.0461
500 TOOTH DISORDER 1024 0.0460
501 GLAUCOMA 884 0.0459
502 INJECTION SITE SWELLING 3513 0.0458
503 PLEURAL EFFUSION 2779 0.0456
504 ORAL PAIN 1021 0.0456
505 WEIGHT FLUCTUATION 477 0.0455
506 FACIAL PARALYSIS 388 0.0455
507 GAIT DISTURBANCE 8708 0.0455
508 IRON DEFICIENCY ANAEMIA 418 0.0452
509 INJECTION SITE PAIN 13879 0.0452
510 DYSSTASIA 1321 0.0452
511 PHOTOSENSITIVITY REACTION 744 0.0450
512 HAND FRACTURE 319 0.0450
513 RESPIRATORY FAILURE 3266 0.0447
514 NEPHROLITHIASIS 2054 0.0447
515 LIMB INJURY 1216 0.0447
516 HIATUS HERNIA 579 0.0447
517 BACK DISORDER 727 0.0447
518 PNEUMOTHORAX 709 0.0447
519 LARGE INTESTINE PERFORATION 310 0.0446
520 GROIN PAIN 392 0.0446
521 RENAL TUBULAR NECROSIS 436 0.0444
522 GASTROINTESTINAL PAIN 488 0.0443
523 LIMB DISCOMFORT 1372 0.0443
524 OXYGEN SATURATION DECREASED 2488 0.0442
525 BLOOD LACTATE DEHYDROGENASE INCREASED 701 0.0442
526 GASTRIC ULCER 837 0.0440
527 INJECTION SITE BRUISING 3513 0.0440
528 KNEE OPERATION 432 0.0439
529 GASTROENTERITIS VIRAL 792 0.0438
530 CARDIAC MURMUR 377 0.0435
531 CLOSTRIDIUM DIFFICILE INFECTION 951 0.0435
532 BLOOD ALBUMIN DECREASED 345 0.0434
533 ANKLE FRACTURE 672 0.0434
534 PULMONARY THROMBOSIS 471 0.0432
535 UTERINE LEIOMYOMA 315 0.0431
536 DRY MOUTH 3486 0.0429
537 SKIN HAEMORRHAGE 636 0.0429
538 URTICARIA 7167 0.0427
539 MOUTH HAEMORRHAGE 313 0.0426
540 BLOOD IRON DECREASED 506 0.0426
541 SKIN REACTION 600 0.0426
542 MUSCULAR WEAKNESS 4780 0.0420
543 PREGNANCY 842 0.0420
544 PRODUCT USE IN UNAPPROVED INDICATION 10394 0.0419
545 DYSPEPSIA 4116 0.0418
546 OEDEMA PERIPHERAL 5092 0.0417
547 COLITIS ULCERATIVE 1866 0.0417
548 CONFUSIONAL STATE 6734 0.0416
549 OFF LABEL USE 36476 0.0416
550 EXPOSURE DURING PREGNANCY 2586 0.0416
551 BLOOD TEST ABNORMAL 584 0.0415
552 INTESTINAL PERFORATION 466 0.0415
553 TUBULOINTERSTITIAL NEPHRITIS 777 0.0414
554 SKIN DISORDER 1382 0.0414
555 OVARIAN CYST 414 0.0414
556 PERICARDIAL EFFUSION 955 0.0413
557 MIGRAINE 3942 0.0413
558 HEPATIC FUNCTION ABNORMAL 1540 0.0412
559 INJECTION SITE RASH 1252 0.0408
560 COAGULOPATHY 679 0.0407
561 MUSCULOSKELETAL CHEST PAIN 629 0.0406
562 INJECTION SITE DISCOLOURATION 507 0.0405
563 VITAMIN D DEFICIENCY 395 0.0405
564 OESOPHAGITIS 442 0.0404
565 DISEASE PROGRESSION 4784 0.0404
566 ADVERSE DRUG REACTION 3631 0.0404
567 SCAB 461 0.0404
568 SKIN CANCER 869 0.0403
569 DENTAL CARIES 446 0.0403
570 BACK PAIN 9346 0.0402
571 GASTRIC DISORDER 1374 0.0400
572 SMALL INTESTINAL OBSTRUCTION 491 0.0399
573 DISEASE RECURRENCE 1889 0.0397
574 NASAL CONGESTION 2324 0.0395
575 EYE INFLAMMATION 377 0.0395
576 PLATELET COUNT INCREASED 514 0.0394
577 RASH PRURITIC 2136 0.0394
578 URINARY TRACT INFECTION 6720 0.0394
579 TOOTHACHE 713 0.0393
580 GASTRITIS 1030 0.0391
581 FATIGUE 30457 0.0391
582 SINUS DISORDER 774 0.0390
583 COUGH 10947 0.0390
584 INJECTION SITE EXTRAVASATION 481 0.0389
585 SPLENOMEGALY 455 0.0388
586 PULMONARY CONGESTION 512 0.0388
587 NERVE INJURY 430 0.0386
588 APPENDICITIS 361 0.0386
589 THERAPEUTIC RESPONSE SHORTENED 1281 0.0386
590 FEMUR FRACTURE 1195 0.0385
591 AORTIC ANEURYSM 293 0.0385
592 SECOND PRIMARY MALIGNANCY 320 0.0384
593 AGRANULOCYTOSIS 714 0.0384
594 ANAEMIA 7293 0.0382
595 DRUG LEVEL INCREASED 630 0.0380
596 INJECTION SITE URTICARIA 933 0.0380
597 BLOOD PRESSURE INCREASED 5792 0.0378
598 ANAPHYLACTIC REACTION 2087 0.0377
599 WEIGHT DECREASED 10525 0.0377
600 POST PROCEDURAL COMPLICATION 719 0.0374
601 MYOPATHY 323 0.0374
602 BEDRIDDEN 490 0.0372
603 HAEMATOCHEZIA 2053 0.0372
604 ABDOMINAL PAIN 8626 0.0370
605 TOXIC EPIDERMAL NECROLYSIS 562 0.0370
606 IMPAIRED QUALITY OF LIFE 532 0.0370
607 MUSCLE STRAIN 320 0.0370
608 WRIST FRACTURE 443 0.0369
609 UPPER LIMB FRACTURE 732 0.0367
610 RECTAL HAEMORRHAGE 1578 0.0367
611 WHITE BLOOD CELL COUNT INCREASED 1405 0.0366
612 HERNIA 707 0.0365
613 LACERATION 341 0.0362
614 CHOLESTASIS 696 0.0362
615 ABDOMINAL PAIN UPPER 7430 0.0361
616 PANCREATITIS 1901 0.0359
617 HYPOPHAGIA 918 0.0359
618 CONJUNCTIVITIS 666 0.0359
619 MALAISE 15714 0.0358
620 BRAIN OEDEMA 452 0.0357
621 THYROID DISORDER 548 0.0355
622 CHOLELITHIASIS 1163 0.0354
623 NEURALGIA 862 0.0354
624 GASTROOESOPHAGEAL REFLUX DISEASE 2847 0.0353
625 ACUTE RESPIRATORY FAILURE 679 0.0353
626 DIABETES MELLITUS 2686 0.0352
627 FLANK PAIN 327 0.0349
628 METASTASES TO LUNG 403 0.0348
629 CHOLECYSTITIS 415 0.0348
630 VOMITING 16365 0.0348
631 EYE DISORDER 1144 0.0348
632 PAIN IN JAW 985 0.0347
633 MOVEMENT DISORDER 1113 0.0346
634 RIB FRACTURE 709 0.0344
635 BLOOD BILIRUBIN INCREASED 929 0.0344
636 HEADACHE 21526 0.0343
637 HIDRADENITIS 313 0.0343
638 DERMATITIS 719 0.0343
639 RASH MACULO-PAPULAR 762 0.0342
640 FRACTURE 648 0.0342
641 RESPIRATORY SYNCYTIAL VIRUS INFECTION 298 0.0342
642 TOOTH EXTRACTION 425 0.0341
643 HAEMATOCRIT DECREASED 674 0.0340
644 ASCITES 999 0.0339
645 INJECTION SITE HAEMORRHAGE 2711 0.0339
646 AFFECT LABILITY 326 0.0338
647 MALNUTRITION 377 0.0337
648 HYPOTHYROIDISM 1075 0.0336
649 NEUTROPHIL COUNT DECREASED 1371 0.0336
650 PULMONARY EMBOLISM 3196 0.0336
651 ASTHMA 3791 0.0335
652 HYPERTENSIVE CRISIS 373 0.0335
653 SCRATCH 352 0.0333
654 MEDICATION ERROR 1852 0.0333
655 DEAFNESS 871 0.0333
656 DEEP VEIN THROMBOSIS 2160 0.0332
657 ADVERSE EVENT 3058 0.0332
658 CHEST PAIN 6135 0.0331
659 PURPURA 293 0.0331
660 METASTASES TO CENTRAL NERVOUS SYSTEM 427 0.0331
661 SNEEZING 741 0.0330
662 RENAL IMPAIRMENT 2767 0.0329
663 GAMMA-GLUTAMYLTRANSFERASE INCREASED 728 0.0328
664 SPINAL FRACTURE 658 0.0328
665 INFLAMMATORY BOWEL DISEASE 321 0.0328
666 HEART RATE IRREGULAR 739 0.0327
667 REBOUND EFFECT 369 0.0326
668 BLOOD CREATININE INCREASED 2130 0.0326
669 QUALITY OF LIFE DECREASED 437 0.0325
670 HAEMORRHOIDS 634 0.0325
671 CORONARY ARTERY OCCLUSION 445 0.0324
672 NAUSEA 25558 0.0323
673 PARAESTHESIA 5077 0.0322
674 ANGINA PECTORIS 921 0.0321
675 ACCIDENT 383 0.0320
676 RESPIRATORY DISTRESS 880 0.0319
677 COLON CANCER 474 0.0318
678 COVID-19 5580 0.0318
679 EATING DISORDER 676 0.0317
680 PETECHIAE 331 0.0317
681 ACUTE KIDNEY INJURY 4829 0.0315
682 DRY EYE 1568 0.0314
683 NEOPLASM 361 0.0314
684 PHOTOPHOBIA 589 0.0313
685 SPINAL OPERATION 385 0.0312
686 AMNESIA 2033 0.0312
687 HEPATIC FAILURE 938 0.0311
688 HYPOKALAEMIA 1436 0.0311
689 SLEEP APNOEA SYNDROME 593 0.0310
690 SEASONAL ALLERGY 439 0.0310
691 METASTASES TO LIVER 543 0.0309
692 OSTEONECROSIS 1014 0.0308
693 HYPOCALCAEMIA 584 0.0308
694 DIARRHOEA 19744 0.0306
695 ASTHENIA 11481 0.0305
696 APHASIA 921 0.0305
697 PRURITUS 11682 0.0304
698 ILEUS 376 0.0302
699 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5449 0.0302
700 MITRAL VALVE INCOMPETENCE 342 0.0302
701 FEELING HOT 1832 0.0299
702 HYPOXIA 1049 0.0298
703 CHOLECYSTECTOMY 339 0.0296
704 DECREASED APPETITE 6877 0.0296
705 PANCREATITIS ACUTE 665 0.0296
706 INFLUENZA LIKE ILLNESS 2435 0.0296
707 WHITE BLOOD CELL COUNT DECREASED 3201 0.0295
708 CARDIOMYOPATHY 436 0.0295
709 MALIGNANT NEOPLASM PROGRESSION 3011 0.0294
710 BODY HEIGHT DECREASED 314 0.0293
711 NEUTROPHIL COUNT INCREASED 300 0.0293
712 TOXICITY TO VARIOUS AGENTS 4934 0.0292
713 HAEMOGLOBIN DECREASED 2991 0.0291
714 SCAR 498 0.0291
715 FALL 9675 0.0290
716 HYPOKINESIA 422 0.0290
717 MYOCARDITIS 332 0.0289
718 CYTOKINE RELEASE SYNDROME 581 0.0289
719 NO THERAPEUTIC RESPONSE 353 0.0289
720 OBSTRUCTIVE AIRWAYS DISORDER 321 0.0288
721 DRUG TOXICITY 393 0.0288
722 GALLBLADDER DISORDER 513 0.0287
723 ERYTHEMA 5899 0.0287
724 ATRIAL FIBRILLATION 2791 0.0286
725 GENERALISED OEDEMA 354 0.0286
726 HAEMOPTYSIS 793 0.0284
727 PROTEINURIA 540 0.0284
728 APHONIA 395 0.0283
729 TACHYCARDIA 2510 0.0282
730 DYSPNOEA EXERTIONAL 1062 0.0282
731 CARDIOMEGALY 346 0.0281
732 HYPERLIPIDAEMIA 335 0.0280
733 RASH PAPULAR 628 0.0280
734 RASH ERYTHEMATOUS 1339 0.0280
735 INJECTION SITE NODULE 308 0.0280
736 SARS-COV-2 TEST POSITIVE 367 0.0278
737 CHILLS 3248 0.0277
738 GOUT 497 0.0277
739 ELECTROLYTE IMBALANCE 321 0.0276
740 FEEDING DISORDER 557 0.0274
741 ACUTE HEPATIC FAILURE 375 0.0274
742 DYSPNOEA 15522 0.0274
743 INSOMNIA 7281 0.0273
744 TACHYPNOEA 371 0.0273
745 ATAXIA 322 0.0271
746 MEMORY IMPAIRMENT 3726 0.0271
747 DEPRESSION 6158 0.0270
748 RED BLOOD CELL COUNT DECREASED 772 0.0270
749 LABORATORY TEST ABNORMAL 796 0.0269
750 RENAL FAILURE 3533 0.0266
751 NERVOUS SYSTEM DISORDER 830 0.0266
752 SKIN DISCOLOURATION 1221 0.0265
753 EPISTAXIS 1976 0.0264
754 THROAT IRRITATION 1185 0.0264
755 ORAL DISCOMFORT 367 0.0264
756 DRUG INTERACTION 4166 0.0262
757 LUNG NEOPLASM MALIGNANT 1075 0.0261
758 BONE DENSITY DECREASED 818 0.0261
759 POOR QUALITY SLEEP 561 0.0260
760 LEUKOCYTOSIS 468 0.0258
761 LYMPHOCYTE COUNT DECREASED 456 0.0258
762 ABDOMINAL DISTENSION 2692 0.0258
763 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1341 0.0257
764 ANOREXIA 331 0.0257
765 PLATELET COUNT DECREASED 2727 0.0256
766 SURGERY 1499 0.0255
767 DYSPHONIA 1489 0.0254
768 INTESTINAL OBSTRUCTION 958 0.0254
769 MUSCLE SPASMS 4656 0.0253
770 GINGIVAL BLEEDING 345 0.0252
771 NEUROPATHY PERIPHERAL 2403 0.0252
772 BLOOD URINE PRESENT 478 0.0252
773 PULMONARY OEDEMA 1126 0.0251
774 HYPERTHYROIDISM 363 0.0250
775 PHARYNGEAL OEDEMA 383 0.0249
776 DYSARTHRIA 937 0.0249
777 HEART RATE INCREASED 2450 0.0247
778 PAIN OF SKIN 665 0.0247
779 BLOOD ALKALINE PHOSPHATASE INCREASED 611 0.0246
780 MACULAR DEGENERATION 293 0.0245
781 COORDINATION ABNORMAL 342 0.0245
782 PERIPHERAL COLDNESS 335 0.0244
783 BLINDNESS UNILATERAL 344 0.0244
784 PROCEDURAL PAIN 676 0.0243
785 EJECTION FRACTION DECREASED 378 0.0243
786 IMPAIRED GASTRIC EMPTYING 331 0.0243
787 ILLNESS 2500 0.0242
788 CEREBRAL INFARCTION 592 0.0242
789 ABASIA 598 0.0242
790 THROMBOSIS 1941 0.0241
791 DYSURIA 888 0.0241
792 RENAL DISORDER 1120 0.0240
793 VERTIGO 1462 0.0240
794 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 406 0.0239
795 VISUAL IMPAIRMENT 2960 0.0239
796 WRONG TECHNIQUE IN DRUG USAGE PROCESS 866 0.0238
797 SKIN FISSURES 465 0.0238
798 RENAL FAILURE ACUTE 1002 0.0236
799 SINUS TACHYCARDIA 334 0.0235
800 HAEMATURIA 805 0.0235
801 FEELING COLD 654 0.0235
802 MUSCLE ATROPHY 297 0.0234
803 NEOPLASM MALIGNANT 1548 0.0232
804 PALLOR 631 0.0232
805 BURNING SENSATION 1624 0.0231
806 CHEST DISCOMFORT 2351 0.0229
807 TRANSIENT ISCHAEMIC ATTACK 765 0.0227
808 CARDIAC FAILURE 1819 0.0226
809 METASTASES TO BONE 371 0.0226
810 MENTAL STATUS CHANGES 623 0.0224
811 DYSPHAGIA 2122 0.0223
812 PRODUCT PRESCRIBING ERROR 532 0.0223
813 ABDOMINAL PAIN LOWER 564 0.0223
814 BLOOD UREA INCREASED 373 0.0223
815 ACTIVITIES OF DAILY LIVING IMPAIRED 441 0.0223
816 PERITONITIS 461 0.0222
817 CORONARY ARTERY DISEASE 672 0.0222
818 HYPOTENSION 4449 0.0222
819 DIZZINESS 11058 0.0221
820 PARALYSIS 317 0.0221
821 INTENTIONAL DOSE OMISSION 631 0.0221
822 OSTEONECROSIS OF JAW 544 0.0220
823 ACUTE MYOCARDIAL INFARCTION 647 0.0219
824 RASH MACULAR 767 0.0219
825 SHOCK 504 0.0219
826 PRURITUS GENERALISED 473 0.0219
827 DIPLOPIA 566 0.0218
828 BLOOD PRESSURE ABNORMAL 433 0.0218
829 HAEMATOMA 561 0.0216
830 BONE PAIN 1268 0.0216
831 HIP FRACTURE 694 0.0216
832 ACCIDENTAL OVERDOSE 785 0.0214
833 BLOOD TRIGLYCERIDES INCREASED 379 0.0214
834 NEOPLASM PROGRESSION 740 0.0213
835 EOSINOPHILIA 369 0.0210
836 HYPERGLYCAEMIA 760 0.0208
837 SWELLING FACE 1357 0.0208
838 DEVICE MALFUNCTION 1449 0.0206
839 PULMONARY HYPERTENSION 429 0.0206
840 ISCHAEMIC STROKE 367 0.0205
841 SUBDURAL HAEMATOMA 294 0.0205
842 BLOOD PRESSURE DECREASED 1362 0.0205
843 SWOLLEN TONGUE 635 0.0203
844 HAEMATEMESIS 513 0.0202
845 SKIN EXFOLIATION 1707 0.0202
846 SENSORY DISTURBANCE 324 0.0202
847 FLUID RETENTION 1025 0.0201
848 HAEMORRHAGE 2105 0.0201
849 URINARY INCONTINENCE 596 0.0201
850 MYALGIA 3420 0.0201
851 LACRIMATION INCREASED 604 0.0200
852 BLOOD POTASSIUM DECREASED 600 0.0199
853 LOSS OF CONSCIOUSNESS 2532 0.0197
854 MULTIPLE FRACTURES 320 0.0195
855 TINNITUS 887 0.0193
856 EYE PAIN 1089 0.0193
857 BLOOD SODIUM DECREASED 363 0.0192
858 HYPONATRAEMIA 1083 0.0192
859 BREAST CANCER 1789 0.0192
860 JAUNDICE 511 0.0190
861 DEHYDRATION 2513 0.0188
862 FACE OEDEMA 317 0.0188
863 BLINDNESS 765 0.0188
864 UNDERDOSE 1369 0.0187
865 PRESYNCOPE 455 0.0187
866 HEAD DISCOMFORT 330 0.0186
867 ANAPHYLACTIC SHOCK 477 0.0185
868 SYNCOPE 1830 0.0183
869 PRODUCT PRESCRIBING ISSUE 397 0.0182
870 ANXIETY 5177 0.0182
871 LETHARGY 1044 0.0181
872 FEELING ABNORMAL 4337 0.0181
873 CIRCULATORY COLLAPSE 308 0.0181
874 MELAENA 398 0.0181
875 ARRHYTHMIA 856 0.0181
876 PALPITATIONS 2100 0.0179
877 ECZEMA 936 0.0179
878 COLD SWEAT 315 0.0179
879 MIDDLE INSOMNIA 333 0.0178
880 GENERALISED TONIC-CLONIC SEIZURE 294 0.0177
881 HEAD INJURY 561 0.0177
882 GASTROINTESTINAL HAEMORRHAGE 1461 0.0175
883 HYPERHIDROSIS 2252 0.0175
884 THROAT TIGHTNESS 472 0.0174
885 UNEVALUABLE EVENT 1298 0.0171
886 DEVICE ISSUE 1534 0.0171
887 RASH GENERALISED 439 0.0169
888 INJECTION SITE MASS 625 0.0169
889 INCORRECT DOSE ADMINISTERED 3855 0.0169
890 CEREBRAL HAEMORRHAGE 604 0.0169
891 NEEDLE ISSUE 486 0.0167
892 RESTLESS LEGS SYNDROME 302 0.0166
893 MYOCARDIAL INFARCTION 2879 0.0165
894 OCULAR HYPERAEMIA 779 0.0164
895 STEVENS-JOHNSON SYNDROME 364 0.0164
896 FAECES DISCOLOURED 353 0.0163
897 PNEUMONIA ASPIRATION 406 0.0162
898 POLLAKIURIA 674 0.0161
899 DEPRESSED MOOD 839 0.0159
900 CEREBROVASCULAR ACCIDENT 2656 0.0157
901 HYPERSOMNIA 447 0.0156
902 TREATMENT NONCOMPLIANCE 850 0.0155
903 VISUAL ACUITY REDUCED 516 0.0155
904 SPEECH DISORDER 804 0.0153
905 URINARY RETENTION 512 0.0153
906 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1085 0.0152
907 CARDIAC FAILURE CONGESTIVE 1218 0.0151
908 DRUG DOSE OMISSION 2502 0.0151
909 HOT FLUSH 1138 0.0151
910 BALANCE DISORDER 1304 0.0151
911 SEIZURE 1729 0.0150
912 EYE SWELLING 556 0.0149
913 TOOTH LOSS 309 0.0149
914 CRYING 538 0.0148
915 METABOLIC ACIDOSIS 472 0.0147
916 NERVOUSNESS 770 0.0147
917 LIP SWELLING 490 0.0147
918 HYPOACUSIS 632 0.0147
919 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 430 0.0147
920 ALTERED STATE OF CONSCIOUSNESS 317 0.0146
921 CONVULSION 836 0.0146
922 CARDIAC DISORDER 1361 0.0145
923 BLOOD CREATINE PHOSPHOKINASE INCREASED 414 0.0144
924 CARDIOVASCULAR DISORDER 358 0.0141
925 CARDIAC ARREST 1161 0.0140
926 FLATULENCE 796 0.0140
927 CONSTIPATION 3028 0.0139
928 VISION BLURRED 1902 0.0138
929 SOMNOLENCE 2787 0.0138
930 RETCHING 291 0.0136
931 ACNE 1034 0.0136
932 DISORIENTATION 540 0.0136
933 INTENTIONAL PRODUCT MISUSE 1175 0.0134
934 ANGIOEDEMA 593 0.0134
935 COMA 638 0.0134
936 THERAPEUTIC RESPONSE UNEXPECTED 588 0.0131
937 CHROMATURIA 295 0.0131
938 COGNITIVE DISORDER 608 0.0130
939 CHRONIC KIDNEY DISEASE 984 0.0129
940 EYE PRURITUS 435 0.0129
941 MENTAL DISORDER 562 0.0129
942 CARDIO-RESPIRATORY ARREST 539 0.0129
943 PRODUCT DOSE OMISSION 841 0.0129
944 TREMOR 2108 0.0127
945 PRODUCT DOSE OMISSION IN ERROR 353 0.0125
946 FLUSHING 1260 0.0124
947 UNRESPONSIVE TO STIMULI 319 0.0123
948 THERAPY CESSATION 629 0.0122
949 THERAPY INTERRUPTED 872 0.0122
950 DEPRESSED LEVEL OF CONSCIOUSNESS 482 0.0122
951 PANIC ATTACK 443 0.0121
952 DEMENTIA 336 0.0120
953 ABORTION SPONTANEOUS 476 0.0119
954 EMOTIONAL DISORDER 365 0.0118
955 DYSGEUSIA 879 0.0118
956 HYPOGLYCAEMIA 562 0.0116
957 BREAST CANCER FEMALE 305 0.0114
958 VAGINAL HAEMORRHAGE 473 0.0109
959 FEAR 293 0.0109
960 FOETAL EXPOSURE DURING PREGNANCY 856 0.0105
961 PRODUCT DOSE OMISSION ISSUE 3071 0.0104
962 DRY SKIN 1391 0.0104
963 BRADYCARDIA 550 0.0104
964 MOOD SWINGS 325 0.0102
965 HOSPITALISATION 1502 0.0098
966 DISTURBANCE IN ATTENTION 519 0.0096
967 HYPERKALAEMIA 336 0.0096
968 EYE IRRITATION 549 0.0095
969 PROSTATE CANCER 765 0.0095
970 SUICIDAL IDEATION 869 0.0095
971 MULTIPLE SCLEROSIS 435 0.0091
972 IRRITABILITY 535 0.0089
973 PRODUCT QUALITY ISSUE 1202 0.0088
974 NIGHTMARE 295 0.0085
975 OVERDOSE 1830 0.0085
976 BLOOD GLUCOSE INCREASED 1576 0.0084
977 DYSKINESIA 334 0.0082
978 AGITATION 571 0.0078
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1467 0.0072
980 ACCIDENTAL EXPOSURE TO PRODUCT 721 0.0070
981 SKIN BURNING SENSATION 494 0.0069
982 DEATH 5896 0.0068
983 BLOOD GLUCOSE DECREASED 328 0.0068
984 SKIN IRRITATION 306 0.0067
985 HALLUCINATION 477 0.0063
986 PRODUCT STORAGE ERROR 551 0.0063
987 NO ADVERSE EVENT 1073 0.0059
988 BLADDER CANCER 331 0.0056
989 SUICIDE ATTEMPT 336 0.0055
990 EMOTIONAL DISTRESS 595 0.0049
991 DRUG DEPENDENCE 564 0.0035